The cost burden of IBD dependent on biologic treatment status

BestPractice | Maalis 2019 | |

This study, a register-based Danish population study, investigated the average annual healthcare costs and production values of patients 10 years before and 8 years after diagnosis, and after initiating biologic treatment.